Lead Poisoning Prevention
Childhood lead poisoning has significant effects on the health of children and on community health. Lead has adverse effects on nearly all organ systems in the body. It is especially harmful to the developing brains and nervous systems of children under the age of six years.
Many of Iowa's pre-1950 homes contain lead-based paint. Young children who live in pre-1950 homes become lead-poisoned when they put paint chips or exterior soil in their mouths or when they get house dust and soil on their hands and put their hands in their mouths. Although lead poisoning can cause serious health problems--including death--most lead-poisoned children demonstrate no visible symptoms. This makes it much more important to have an effective program to prevent childhood lead poisoning.
For more information about Lead Poisoning Prevention, please Contact Us or call 1-800-972-2026.
- Click here to download our new Lead Safety Brochure Black & White Version - Last updated: October 2017
FDA Issues Warning on Magellan LeadCare Analyzers
The U.S. Food and Drug Administration (FDA) has issued a safety communication warning about the use of Magellan Diagnostics’ LeadCare® analyzers (LeadCare, LeadCare II, LeadCare Ultra and LeadCare Plus) with venous blood samples because they might result in falsely low test results. FDA is now advising that Magellan Diagnostics’ LeadCare® analyzers should no longer be used with venous blood samples. The safety alert does not apply to capillary blood lead test results collected by fingerstick or heelstick. The purpose of this Health Advisory is to notify state and local health departments, healthcare providers, and laboratories about CDC’s re-testing guidance in light of the safety alert.
CDC recommends that healthcare providers re-test patients who:
1) are younger than 6 years (72 months) of age at the time of the alert (May 17, 2017) and
2) had a venous blood lead test result of less than 10 micrograms per deciliter (µg/dL) analyzed using a Magellan Diagnostics’ LeadCare® analyzer at an onsite (e.g., healthcare facility) or at an offsite laboratory.
CDC also recommends that healthcare providers re-test currently pregnant or lactating women who had a venous blood lead test performed using a Magellan Diagnostics’ LeadCare® analyzer.
CDC recommends parents discuss re-testing with their healthcare provider or health department to determine if their child’s blood should be re-tested.
The Iowa Department of Public Health (IDPH) only recognizes venous blood lead tests analyzed by an approved laboratory as a confirmed valid result. IDPH guidelines recommend children less than 6 years in age (<72 months) be retested if their lead result from a Magellan LeadCare system is equal to or greater than 10 micrograms per deciliter.
For More Information
CDC’s Lead Poisoning Prevention Program: https://www.cdc.gov/nceh/lead/
CDC’s Lead and Multi-element Proficiency Program: https://www.cdc.gov/labstandards/lamp.html
FDA safety communication warning, May 17, 2017. Available at:
Questions? Contact the Iowa Lead Poisoning Prevention Program at 800-972-2026.